SCHEMBL2977607

SCHEMBL2977607

COC(=O)c1cc(N(CCO)CCO)c([N+](=O)[O-])cc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.44
PDGFRB P09619 1/20 0.43
FGFR1 P11362 1/20 0.43
PDGFRA P16234 1/20 0.43
FLT1 P17948 1/20 0.43
FGFR3 P22607 1/20 0.43
KDR P35968 1/20 0.43
HCAR3 P49019 1/20 0.41
SIRT6 Q8N6T7 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 1/20 0.40
VCAM1 P19320 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 2/20 0.38
NSD2 O96028 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8638762 0.88 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2PDGFRBFGFR1
SCHEMBL3583697 0.85 VCAM1 (0.48) ALDH1A1KDM4ESMN1; SMN2PDGFRBFGFR1
SCHEMBL2966761 0.83 VCAM1 (0.43) ALDH1A1KDM4ESMN1; SMN2PDGFRBFGFR1
SCHEMBL3421496 0.76 MAPT (0.46) ALDH1A1KDM4ESMN1; SMN2HCAR3TDP1
SCHEMBL3421607 0.76 ALDH1A1 (0.46) ALDH1A1KDM4ESMN1; SMN2HCAR3TDP1
SCHEMBL3424399 0.76 ALDH1A1 (0.46) ALDH1A1KDM4ESMN1; SMN2HCAR3TDP1
SCHEMBL13037508 0.76 PDGFRB (0.48) ALDH1A1KDM4ESMN1; SMN2PDGFRBFGFR1
SCHEMBL13680345 0.75 TDP1 (0.53) ALDH1A1KDM4ESMN1; SMN2PDGFRBFGFR1
SCHEMBL12604704 0.75 PDGFRB (0.56) ALDH1A1KDM4ESMN1; SMN2PDGFRBFGFR1
SCHEMBL3585341 0.74 VCAM1 (0.47) PDGFRBFGFR1PDGFRAFLT1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776924-B2 Nitroaniline-based alkylating agents and their use as prodrugs AUCKLAND UNISERVICES LIMITED (NZ) 2010-08-17 US disclosed
US-20050256191-A1 Nitroaniline-based alkylating agents and their use as prodrugs AUCKLAND UNISERVICES LIMITED (NZ) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256191-A1 Nitroaniline-based alkylating agents and their use as prodrugs IDH3A, HIF1AN, IDH1 ALDH1A1 325/4885KDM4E 1057/4885SMN1; SMN2 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.